EZH2 inhibition promotes tumor immunogenicity in lung squamous cell carcinomas
T. J. DuCote, X. Song, K. Naughton, F. Chen, D. R. Plaugher, A. R. Childress, A. R. Edgin, X. Qu, J. Liu, J. Liu, F. Li, K.-K. Wong, C. F. Brainson
EZH2 inhibition increases immune checkpoint inhibitor response in lung squamous cell carcinomas by enhancing antigen presentation and immune cell infiltration.
bioRxiv · Jun 6, 2023Cancer Biology